🔎 Trials Near Me

Home › Castration-Resistant Prostatic Cancer › Texas › Houston

Castration-Resistant Prostatic Cancer clinical trials in Houston, TX

6 studies for Castration-Resistant Prostatic Cancer are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

RecruitingPhase 3
  • Houston Metro Urology, Houston
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07225946

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

RecruitingPhase 3
  • MD Anderson Cancer Center, Houston
  • Michael E DeBakey VA Medical Center, Houston
Ages 18 and older · Men · Updated Sep 25, 2026 · NCT07164443

A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

RecruitingPhase 1
  • NEXT Houston, Houston
Ages 18 and older · Men · Updated Sep 24, 2026 · NCT07719361

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

RecruitingPhase 1
  • Investigational Site Number: 401, Houston
Ages 18 and older · Men · Updated Sep 10, 2026 · NCT05997615

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

RecruitingPhase 1
  • Houston Methodist Hospital, Houston
Ages 18 to 100 · Men · Updated Aug 13, 2026 · NCT05519449

A Study of MGC026 in Participants With Advanced Solid Tumors

RecruitingPhase 1
  • The University of Texas MD Anderson Cancer Center, Houston
  • University of Texas Health Science Center at Houston, Houston
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT06242470

Castration-Resistant Prostatic Cancer trials in other cities

Other studies in Houston

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.